Growing And Innovating As A CDMO Business
Rentschler CEO Frank Mathias Sheds Light On The Company’s Strategy For The 2020s
Executive Summary
Frank Mathias, CEO of Rentschler Biopharma, a contract development and manufacturing organization, talks to In Vivo about the company’s new corporate strategy and why he allowed 18 months to prepare that plan for delivery.
You may also be interested in...
Infographic: 20 Years Of Mega-Deals
The biopharma sector is often accused of a being a slow-moving engine, but a look back over the last 20 years reveals that a lot has changed. In Vivo explores the history of high-impact M&A transactions in the industry between 1999 and 2019.
Investing In People: Aligning VCs And Today’s Entrepreneurs
In the latest instalment of our VC playbook series, In Vivo sits down with Roel Bulthuis, managing partner at INKEF Capital, to discuss the group’s approach to health care investing in Europe, the importance of funding a team not just a project and how life sciences venture capital is evolving with the emergence of health tech.
Deals Of The Year 2019 Winners Announced
Our readers have been voting and the results have been counted. The winners of In Vivo's annual Deals Of The Year contest are ...
Need a specific report? 1000+ reports available
Buy Reports